
|Articles|April 21, 2008
Treximet, a sumatriptan and naproxen combination treatment, approved for migraine
GlaxoSmithKline gets FDA nod for combination migraine treatment
Advertisement
Acute migrane sufferers will now have a new option for treatment with a
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Metformin Cuts Long COVID Risk by Half in New ACTIV-6 Trial Results
2
FDA Approves Utebzi as First Oral Carbapenem for Complicated UTIs
3
Oral Orforglipron for Obesity Management
4
FDA Committee Votes Unanimously to Recommend mRNA Flu Vaccine
5




































